July 20, 2017 / 1:10 PM / 2 months ago

BRIEF-Diffusion Pharma achieves drug production milestone

July 20 (Reuters) - Diffusion Pharmaceuticals Inc:

* Diffusion Pharmaceuticals achieves drug production milestone for planned phase 3 clinical trial in inoperable GBM brain cancer

* Says ‍diffusion plans to initiate this clinical trial by end of 2017​

* Diffusion Pharmaceuticals- interacting with FDA regarding design, execution of planned phase 3 study, with initiation planned for later this year​

* Diffusion-Planned studies include phase 2 trials in pancreatic cancer, brain metastases; initiation subject to receipt of funding/collaborative partnering Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below